Sanjay Keswani's Insider Trades & SAST Disclosures

Sanjay Keswani's most recent trade in Neurocrine Biosciences, Inc. was a trade of 70,101 Stock Option done . Disclosure was reported to the exchange on June 2, 2025.

Share

Note

This is a custom search result for pattern Sanjay Keswani.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Neurocrine Biosciences Inc	Sanjay Keswani	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jun 2025	70,101	70,101	-		-	Stock Option
Neurocrine Biosciences Inc	Sanjay Keswani	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jun 2025	12,846	12,846	-		-	Restricted Stock Unit
Annexon Inc High Gain High Volume	Sanjay Keswani	EVP & Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Feb 2022	100,000	100,000	-		-	Stock Option (Right to Buy)
Annexon Inc High Gain High Volume	Sanjay Keswani	EVP & Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Feb 2022	12,500	12,500	-		0	Common Stock
Annexon Inc High Gain High Volume	Sanjay Keswani	EVP & Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 30.17 per share.	24 Mar 2021	3,995	0	-	30.2	120,512	Common Stock
Annexon Inc High Gain High Volume	Sanjay Keswani	EVP & Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Mar 2021	3,995	182,956	-		-	Stock Option (Right to Buy)
Annexon Inc High Gain High Volume	Sanjay Keswani	EVP & Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.49 per share.	24 Mar 2021	3,995	3,995	-	7.5	29,917	Common Stock
Annexon Inc High Gain High Volume	Sanjay Keswani	EVP & Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Feb 2021	115,000	115,000	-		-	Stock Option (Right to Buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades